Veeva Systems (NYSE:VEEV) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Veeva Systems (NYSE:VEEV) issued its earnings results on Wednesday. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10, FiscalAI reports. Veeva Systems had a net margin of 28.37% and a return on equity of 13.89%. The business had revenue of $882.95 million for the quarter, compared to analyst estimates of $857.73 million. During the same quarter in the prior year, the business posted $1.97 EPS. The company’s revenue for the quarter was up 16.3% on a year-over-year basis. Veeva Systems updated its FY 2027 guidance to 9.050-9.050 EPS and its Q2 2027 guidance to 2.210-2.220 EPS.

Here are the key takeaways from Veeva Systems’ conference call:

• Veeva said it had a strong start to the year, with Q1 revenue of $883 million and non-GAAP operating income of $395 million, both ahead of guidance.
• The company is leaning heavily into Falcon and its broader MAP architecture (models, agents, applications), positioning AI agents to perform standardized life sciences labor such as document processing, safety case triage, and regulatory correspondence.
• Vault CRM momentum remains strong, with over 150 customers live, more than 40 migrations completed, and a stated win rate above 80% in the top 20 pharma account set.
• Veeva highlighted continued strength in Crossix, citing innovation in new measurement channels and durable market share gains in a healthy digital advertising market for pharma.
• The newly acquired Ostro business is being run as a startup within Veeva and is expected to contribute about $10 million in the remaining three quarters of the year, with management describing it as additive rather than cannibalistic to the core business.

Veeva Systems Price Performance

NYSE VEEV opened at $178.56 on Friday. The company has a market capitalization of $29.16 billion, a P/E ratio of 31.83, a PEG ratio of 0.79 and a beta of 0.95. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50. The company’s 50 day simple moving average is $166.27 and its 200 day simple moving average is $195.90.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva beat first-quarter estimates, with EPS of $2.24 and revenue of $882.9 million, while Q2 revenue guidance also came in above expectations, supporting the case for continued growth. Article Title
• Positive Sentiment: Management raised fiscal 2027 outlook and highlighted AI initiatives, including Falcon AI agents and new platform expansion, which could improve investor sentiment around product innovation and future monetization. Article Title
• Positive Sentiment: Several brokers remain constructive, with firms like Oppenheimer, RBC, Needham, BTIG, and Baird reiterating bullish ratings and high price targets, suggesting some analysts see meaningful upside despite the recent pullback.
• Neutral Sentiment: Other analysts turned more cautious, including Goldman Sachs, UBS, BMO, and Citigroup, which lowered price targets, adding to the mixed read-through from the earnings report.
• Negative Sentiment: Some commentary pointed to concerns about the legacy CRM business and customer migration dynamics, which may be tempering enthusiasm around the AI story and weighing on the shares.

Insider Activity at Veeva Systems

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the company’s stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the sale, the director directly owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Veeva Systems

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. State Street Corp lifted its holdings in shares of Veeva Systems by 2.4% in the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company’s stock valued at $801,267,000 after purchasing an additional 85,695 shares in the last quarter. AQR Capital Management LLC lifted its stake in Veeva Systems by 31.2% in the 3rd quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock worth $706,078,000 after acquiring an additional 574,164 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Veeva Systems by 12.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,728,089 shares of the technology company’s stock worth $385,761,000 after acquiring an additional 189,093 shares in the last quarter. Wellington Management Group LLP boosted its position in Veeva Systems by 1.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,466,827 shares of the technology company’s stock worth $436,982,000 after acquiring an additional 18,349 shares during the period. Finally, Bank of America Corp DE grew its stake in Veeva Systems by 11.4% during the 3rd quarter. Bank of America Corp DE now owns 1,419,717 shares of the technology company’s stock valued at $422,948,000 after acquiring an additional 144,982 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on VEEV shares. TD Cowen reaffirmed a “buy” rating on shares of Veeva Systems in a report on Thursday. Canaccord Genuity Group dropped their price target on Veeva Systems from $235.00 to $220.00 and set a “hold” rating on the stock in a research report on Thursday. UBS Group reduced their price objective on Veeva Systems from $220.00 to $190.00 and set a “neutral” rating on the stock in a research note on Thursday. Evercore reiterated an “outperform” rating and set a $185.00 target price on shares of Veeva Systems in a research note on Thursday. Finally, Citigroup increased their target price on shares of Veeva Systems from $176.00 to $190.00 and gave the stock a “neutral” rating in a report on Thursday. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $250.96.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.